
Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
SilverLeaf Investments is a venture capital firm based in South Africa, established in early 2021. It is recognized as the country's first cannabis-focused VC, operating under a Section 12J Venture Capital Company (VCC) structure. This tax-incentivized framework allows both retail and institutional investors to participate in the burgeoning cannabis market, which is projected to achieve significant financial milestones in the coming years.
The firm is dedicated to unlocking the value of the cannabis and hemp industry by investing in small, medium-sized, and micro enterprises (SMMEs) across the entire cannabis value chain. SilverLeaf's approach includes active management support and structured entrepreneurship development programs, such as the GreenHouse Accelerator, which prepares cannabis-related businesses for investment readiness.
As of now, SilverLeaf Investments has a portfolio of three companies and is actively developing a cannabis crowd-funding platform called GoGetta to provide capital for cannabis startups. The firm is headquartered in South Africa and has plans to expand its influence within the cannabis sector.
SilverLeaf Investments specializes in the entire cannabis value chain, which encompasses cultivation, processing, manufacturing, distribution, retail, and ancillary services. The firm targets investments in early-stage companies and those at the scale-up stage, ensuring compliance with existing legislation. Their investment strategy is designed to identify and build a pipeline of investable cannabis SMMEs across South Africa.
The firm focuses on sectors such as healthcare and consumer products, particularly those related to cannabis. SilverLeaf seeks to incubate businesses that demonstrate potential for both local and international success. The check size range for investments typically starts at $500,000 and can go higher, with a minimum investment requirement of R500,000 (approximately $27,000). SilverLeaf's investment stages include pre-seed, seed, seed-plus, and Series A.
SilverLeaf Investments has made notable investments in three companies within the cannabis sector:
Additionally, SilverLeaf is developing a cannabis crowd-funding platform called GoGetta, which aims to provide capital for cannabis startups while allowing public investment in the industry.
Darryl Weisz - CEO: Darryl has extensive experience in the cannabis industry and leads SilverLeaf Investments with a vision to capitalize on the growing market. He has been instrumental in establishing the firm and its investment strategies.
Pierre van der Hoven - Non-Executive Director: Pierre brings a wealth of knowledge in venture capital and business development, contributing to the strategic direction of SilverLeaf Investments.
To pitch SilverLeaf Investments, founders should submit their proposals through the online application form available at Apply for Funding. The pitch deck should include detailed information about the business model, market analysis, and compliance with regulations. SilverLeaf prefers well-structured proposals that clearly outline the investment opportunity.
Response times may vary, but founders can expect to hear back after their proposals have been reviewed. Warm introductions are beneficial but not mandatory.
SilverLeaf Investments operates the GreenHouse Accelerator, a structured entrepreneurship development program aimed at preparing cannabis-related businesses for investment readiness. This three-month program includes mentorship and education tailored to the cannabis sector.
Additionally, the firm runs the SilverLeaf Business Accelerator, which focuses on identifying and building a pipeline of investable cannabis SMEs across South Africa's full cannabis value chain.
In July 2022, SilverLeaf Investments was listed on EasyEquities, aiming to raise R7 million in equity. This listing marked a significant milestone for the firm, making it accessible to retail investors.
In July 2023, the firm was featured in Engineering News for its SilverLeaf Business Accelerator, which is designed to identify and build a pipeline of investable cannabis SMEs across South Africa.
What are SilverLeaf Investments' investment criteria?
SilverLeaf Investments focuses on the cannabis and hemp industry, targeting small, medium-sized, and micro enterprises (SMMEs) across the entire cannabis value chain. They look for businesses that demonstrate potential for local and international success and ensure compliance with existing legislation.
How can I apply or pitch to SilverLeaf Investments?
Interested parties can apply for funding through their website at Apply for Funding. They encourage detailed proposals that outline the business model, market potential, and compliance with regulations.
What makes SilverLeaf Investments different from other VCs?
SilverLeaf is unique as South Africa's first cannabis-focused venture capital firm. They provide a tax-incentivized structure for investors and actively support their portfolio companies through mentorship and structured development programs like the GreenHouse Accelerator.
What is the geographic scope of SilverLeaf Investments?
The firm primarily focuses on investments within South Africa, targeting cannabis-related businesses that comply with local legislation.
What is the typical check size for investments?
SilverLeaf Investments typically invests a minimum of R500,000 (approximately $27,000), with check sizes generally starting at $500,000 and above.
What is SilverLeaf's post-investment involvement like?
SilverLeaf provides active management support and mentorship to its portfolio companies, helping them navigate the complexities of the cannabis industry and prepare for future investment rounds.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.